As India battles another record spike in infections, with over 1.8 lakh news cases on Tuesday, 13 April, we finally also received some good news. After a long wait, on 12 April, Russia's Sputnik V became the third vaccine to be green-lit for emergency use in India.
The Sputnik V approval comes after the Centre finally eased the path for vaccines from pharmaceutical companies that are approved in the US, the UK and European countries, to seek approvals in India.
Sputnik V is also one of the only three clinically tested vaccines in the world (including Pfizer and Moderna) with an efficacy of 91.6 percent as per The Lancet’s findings.
Meanwhile, on the side of the world, another popular vaccine is now being temporarily paused. The vaccine in question is the single-shot Johnson and Johnson vaccine after multiple cases of severe blood clots were reported on 13 April.